Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
01/2000
01/12/2000EP0970053A1 5-oxysubstituted chinolines and their use as cholesterol ester transfer proteins inhibitors
01/12/2000EP0970046A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
01/12/2000CN1048242C 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid deriv. and its preparing process, and intermediate compound
01/11/2000US6013651 Meta-azacyclic amino benzoic acid compounds and derivatives thereof
01/06/2000WO2000000475A1 Substituted quinolin-2(1h)-ones useful as hiv reverse transcriptase inhibitors
01/06/2000WO1999043661A3 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
01/06/2000CA2333643A1 Substituted quinolin-2(1h)-ones useful as hiv reverse transcriptase inhibitors
01/05/2000EP0968250A1 Soluble chromophores having improved solubilising groups
01/05/2000EP0968201A2 New aminopiperazine derivatives
01/05/2000EP0968182A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
01/05/2000EP0968179A1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides
01/05/2000EP0968164A1 Bicyclic quinone compounds, their production and use
01/05/2000EP0776884B1 Substituted amide derivative
01/05/2000EP0675880B1 Quinoline disulfides as intermediates
01/05/2000CN1240212A Process for reducing prochiral ketone to produce optically active alcohol of high optical purity
01/04/2000US6011175 Inhibition of farnesyltransferase
01/04/2000US6011033 Phenylene derivatives
12/1999
12/29/1999WO1999067208A1 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids
12/29/1999WO1999067201A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release
12/29/1999WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors
12/29/1999WO1999054326A8 Dihydropyrimidines
12/29/1999EP0966473A1 Thiazolobenzoheterocycles, preparation and medicines containing same
12/29/1999EP0966443A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
12/29/1999EP0966442A1 Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity
12/29/1999EP0966436A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/29/1999CA2335513A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release
12/29/1999CA2335373A1 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids
12/29/1999CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors
12/28/1999US6008230 Treating bone diseases caused by abnormal bone metabolism in human being or animals as the inhibitors of bone resorption or the inhibitors of bone metastasis
12/28/1999US6008229 Treating allergy, inflammation, autoimmune disease, shock, pain
12/28/1999US6008204 Antidotes for preventing certain undesired side effects of retinoids
12/23/1999WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999CA2333554A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/22/1999EP0965068A1 Photosensitive quinolone compounds and a process of preparation
12/22/1999CN1239474A Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents
12/22/1999CN1239094A Process for preparing quinolone- and naphthyridonecarboxylic acids and esters thereof
12/21/1999US6005111 Color developing agent, processing composition and color image-forming method
12/21/1999US6004979 Angiotensin ii inhibitors; 4-((carboxy)aryloxy)-quinoline derivatives
12/21/1999US6004975 Anxiolytic agents with side effect reduction
12/21/1999US6004903 2-Anylocyclohexanediones having improved herbicidal properties
12/16/1999WO1999064411A1 Tetrahydroquinoline derivatives as glycine antagonists
12/16/1999WO1999064394A1 Neuropeptide y5 receptor antagonists
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064054A1 Multibinding inhibitors of topoisomerase
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064051A1 Novel antibacterial compounds
12/16/1999WO1999064049A1 Novel antibacterial agents
12/16/1999WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999WO1999064047A1 Novel antiviral compounds
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064039A1 Bradykinin antagonists
12/16/1999WO1999064038A1 Novel analgesic agents
12/16/1999WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999WO1999064032A1 Combinatorial synthesis of multibinding libraries
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063994A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999WO1999063940A2 INHIBITORS OF H+K+-ATPase
12/16/1999WO1999063939A2 Multibinding inhibitors of cyclooxygenase-2
12/16/1999WO1999063937A2 Multivalent macrolide antibiotics
12/16/1999WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999DE19826050A1 Verfahren zur Herstellung von Chinolon- und Naphthyridoncarbonsäuren und deren Ester Process for the preparation of quinolone- and naphthyridonecarboxylic acids and esters thereof
12/16/1999CA2321274A1 Novel antiviral compounds
12/16/1999CA2321273A1 Novel analgesic agents
12/16/1999CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999CA2321162A1 Novel antibacterial compounds
12/16/1999CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999CA2320290A1 Multibinding inhibitors of cyclooxygenase-2
12/16/1999CA2320241A1 Multivalent macrolide antibiotics
12/16/1999CA2319761A1 Multibinding inhibitors of hmg-coa reductase
12/16/1999CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999CA2319730A1 Bradykinin antagonists
12/16/1999CA2319651A1 H1-histamine receptor antagonists
12/16/1999CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999CA2319495A1 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999CA2319477A1 Inhibitors of h+k+-atpase
12/16/1999CA2319474A1 Inhibitors of nitric oxide synthase
12/16/1999CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
1 ... 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 ... 277